Stock Market News For December 09, 2016

 | Dec 08, 2016 10:25PM ET

Markets finished at record highs again on Thursday following ECB’s announcement about trimming bond-buying volume and the continuing Trump induced rally. Meanwhile, decline in initial claims also added to the optimism. Moreover, strong gains in financials and rebound in healthcare sector also played a vital role in boosting the major benchmarks. While the Dow and S&P 500 again hit all-time record levels, the Nasdaq reached all-time high during intraday trading.

For a look at the issues currently facing the markets, make sure to read today’s Ahead of Wall Street article .

The Dow Jones Industrial Average (DJI) rose 0.3% to close at 19,614.81. The S&P 500 increased 0.2% to close at 2,246.19. The tech-laden Nasdaq Composite Index closed at 5,417.36, gaining more than 0.4%. However, the fear-gauge CBOE Volatility Index (VIX) rose nearly 3.2% to settle at 12.60. A total of around 8 billion shares were traded on Thursday, higher than the last 20-session average of 7.8 billion shares. Advancers outpaced declining stocks on the NYSE. For 60% stocks that advanced, 37% declined.

What Factors Boosted Benchmarks?

In their policy meeting yesterday, the European Central Bank (ECB) policymakers decided that it will extend its bond-purchasing program at least until December of next year. However, they also decided to cut the volume of bond purchasing from 80 billion euros ($86 billion) per month to 60 billion euros since coming April. Meanwhile, the ECB also revised the inflation outlook for 2017 upward from 1.2% to 1.3%. Though investor’s sentiment got dampened in the early session following news of extension in the bond-purchasing program, but later it rebounded on the back of the central bank’s announcement of trimming the volume of the program.

This along with continued broad based rally following Trump’s victory in the Presidential election led financial stocks to emerge as the top gainer among broader sectors. The Financial Select Sector SPDR (XLF) gained more than 0.9% and was the biggest gainer among the S&P 500 sectors. Key stocks from this sector including The Goldman Sachs Group (NYSE:GS), Inc. (BAC ) gained 2.5%, 2.2% and 1.7%, respectively.

Separately, after being dragged down by Trump’s comments on reducing drug prices on Wednesday, biotech stocks along with the broader healthcare sector made an impressive rebound yesterday. The iShares Nasdaq Biotechnology ETF (IBB) and Health Care Select Sector SPDR (XLV) gained 0.8% and 0.2%, respectively. Key stocks from this sector including Celgene Corporation (NASDAQ:CELG) ( .

Moreover, jobless claims decreased by 10,000 from the earlier week to 258,000 for the week ending Dec 3, according to the Department of Labor. However, it came slightly higher than the consensus estimate of 256,000.

Stocks That Made Headlines

Humana (NYSE:HUM) to Write off Receivables; Updates Guidance

Humana Inc. (Read More )

NCI Building (NCS) Lags Q4 Earnings & Revenue Estimates

NCI Building Systems Inc. (Read More )

Confidential: Zacks' Best Investment Ideas

Would you like to see a hand-picked "all-star" selection of investment ideas from the man who heads up Zacks' trading and investing services? Steve Reitmeister knows when key trades are about to be triggered and which of our experts has the hottest hand.Zacks Investment Research

Get The News You Want
Read market moving news with a personalized feed of stocks you care about.
Get The App

Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

Sign out
Are you sure you want to sign out?
NoYes
CancelYes
Saving Changes